Briacell Therapeutics
Quarterly Financials
| Values in thousands | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $225 |
Gross Profit | -33 | -27 | -26 | -36 |
EBITDA | -7,174 | -7,640 | -11,627 | -11,653 |
EBIT | -7,207 | -7,668 | -11,665 | -11,689 |
Net Income | -7,164 | -7,352 | -11,489 | -11,057 |
Net Change In Cash | 0 | 0 | 0 | 225 |
Free Cash Flow | -7,205 | -7,967 | -10,690 | -11,203 |
Cash | 6,880 | 29,903 | 2,714 | 14,428 |
Basic Shares | 7,250 | 2,802 | 1,883 | 1,883 |
Annual Financials
| Values in thousands | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -82 | -15 | -15 |
EBITDA | -4,849 | -31,060 | -34,399 |
EBIT | -4,933 | -31,080 | -34,418 |
Net Income | -4,793 | -27,114 | -34,420 |
Net Change In Cash | 0 | 0 | 0 |
Cost of Revenue | -16,227 | ||
Free Cash Flow | -33,592 | -31,891 | -15,874 |
Cash | 1,196 | 28,381 | 52,634 |
Basic Shares | 1,096 | 1,041 | 1,032 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-04-30 | -$0.98 |
2026-01-31 | -$2.57 |
2025-10-31 | -$4.35 |
2025-07-31 | -$9.24 |